A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the central nervous system–including the retina of the eye–serve as “gatekeepers,” or biosensors and facilitators, of neuroinflammation in a preclinica…
Ophthalmologists push for better access to care in annual Capitol Hill visit
In an effort to lobby for better access to care, discuss important issues with lawmakers and increase education, more than 400 ophthalmologists traveled to Washington recently for the American Academy of Ophthalmology’s annual Capitol Hill visit.Michae…
Physicians’ Education Resource® Hosts the 2019 New York Cardio-Endo-Renal Collaborative
CRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® Hosts the 2019 New York Cardio-Endo-Renal Collaborative
Rocklatan approval tops recent glaucoma news
The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on Healio.com/OSN in recent weeks.Here are the top five recent glaucoma stories: FDA approves Rocklatan for o…
MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
Williams Syndrome, a rare neurodevelopmental disorder that affects about one in 10,000 babies born in the United States, produces a range of symptoms including cognitive impairments, cardiovascular problems, and extreme friendliness, or hypersociability.
Bausch + Lomb to initiate clinical trials for Technolas Teneo excimer laser
Bausch + Lomb will begin a clinical trial series of its Technolas Teneo excimer laser for vision correction surgery, the company announced in a press release.Designed to correct myopia and myopic astigmatism, the Technolas Teneo laser system is the sam…